DATA AVAILABILITY STATEMENT:
The data that support the findings of this study are available from the authors are available upon reasonable request.
KEY CLINICAL MESSAGE:We report on the successful use of chemotherapy for treatment of stage 2B testicular seminoma in a carrier of the Leber’s Hereditary Optic Neuropathy 11778 mitochondrial mutation. Neurotoxic chemotherapy may not prompt disease conversion.